Lactate Dehydrogenase-to-Albumin Ratio and Ventricular Aneurysm Risk in STEMI Patients

A Chinese multi-center study from July 2018 to 2025 analyzed the predictive ability of the lactate dehydrogenase to albumin ratio (LAR) for left ventricular aneurysm (LVA) in ST-segment elevation myocardial infarction (STEMI) patients. The dataset includes results from three cohorts totaling 551, 471, and 1384 participants who underwent primary percutaneous coronary intervention. Author Dong Hu published the findings on figshare under a CC-BY-4.0 license.

Use Cases

• Predicting left ventricular aneurysm risk based on biomarker ratios.
• Validating the LAR metric as an independent predictor for cardiac complications.
• Training logistic regression models for clinical outcome prediction using multi-center data.
• Conducting subgroup analyses to assess biomarker consistency across patient cohorts.

Strengths

• Data originates from three distinct medical center cohorts, providing multi-source validation.
• Results include specific odds ratios and confidence intervals (e.g., OR=6.01, 95% CI=2.22-16.26) for the association between LAR and LVA.
• The study employed multivariate logistic regression and restricted cubic spline analysis, suggesting a structured analytical approach.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• The 11.4 KB file size indicates a very small dataset, likely containing summary statistics rather than patient-level records.

Provenance

Source

figshare

Collection Method

Clinical study data collected from three medical centers in China.

Time Range

July 2018 to 2025

Freshness

Last updated 2026-05-13 04:30:13; freshness should be verified.

Geography

China